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    It is becoming increasingly apparent that many microorganisrns that are not ordinarily． considered
pathogcnic or virulent may， under certain circumstances， become so when the immunologic capacity
of the host is impaired． These infections are referred to as opportunistic infectlons （e．g．， Pseudemonas
aeruginosa or Serratia marcescens） and are assuming increasing clinical importance in the urological
field as the number of patients with compromised defense mechanisms．
    Host defenses against bacterial infections are at． once local and systemic， non－specific and spe－
cific， however nen－specific defense mechanism firstly react to bacterial infection． After bacterial
infection occur， microorganisms may be engulfed by wandering tissue macrophages and polymor－
ph・nu・1・a・（PNM）1・uk・cyt・…m・n・・yt・・emig・at・d fr・m ・．4pill・・y…sel・at th・・it・・fin且・m皿・tρ・y
change． These cellular elements， especially PMN leukocytes， are phagocytes of invaded micro－
organisms． Accumulation of PMN leukocytes in local tissue sites infected with microorganisms is
an impo．rtant event in the host defense from the point of view qbove these facts． PMN leukocyte
chemotaxis is an impo；tant stage for the first step of PMN’@leukocyte function as phagocytosis． I
studied PMN leukocyte chemotaxis with 20 patients having pyelonephritis or bladder tumor using
an agarose plate technique， and furthermore stu．died the effect offive different antibiotics on chemotaxis
of PMN leukocytes with the patients of pyelonephritis．
    QLuantitation of chemotaxis was dQne by meas．uring in centimeters the linear distance the cells
have migrated from the margin of the well toward the bacterial chemotatic factor． Random mobility
was represented by the distance the cells have migratcd from the well margin toward the control medium．
Linear distances of PMN leukocyte migration was done under inicroscopic measurement （× 40）．
    The results were summarized in the followings．
［A］ Group of pyelonephritis．
    1） Leukocytes from 20 patients and 30．healthy ’subjects （control） were examined． ln all
patients， the vaiue of PMN leukocyte chemotaxis was higher than in the controls． The mean value
of PMN leukocyte chepaotaxis in pa’tients was 5．2±O．2 cm， and ！he’mean value in the controls was
3．3圭0．1cm；this difference was statistically significant（p＜0。001）． The mcan value of rando．m
mobility i1120 patients was 3．1±0．2 cm， and the meanvalue in the controls was I．5土0・l cm・
Random mobility also was enhanced in 20 patients compared with normal subjects； this ． difference
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was found to be statistically significant （p〈O．OOI）． This results demonstrated an enhancement in
the chemotactic response of leukocytes derived from patients． lt has been shown experimentally
that increases in the intra－leukocytic level of cyclic GMP enhance eheniotaxis， while increases in the
level of cyclic AMP inhibit chemotaxis． lt seems logical to assupae that a decreased cyclic AMPI
cyclic GMP ratio， similar to the imbalance between these 2 cyclic nucleotides found in the patients，
might also be present in leukocytes derived from patients with pyelonephritis．
    2） The results of the effect of five different antibiotics on PMN leukocyte chernotaxis with the
pa．tients of pyelonephritis were summarizgd in the followings； （a） There was no effect of beta－lactam
antibiotics （CBPC， CER） on ．the chemotaxis． （b） Tetracycline of the therapeutic blood level
（3．12 pg／ml） appeared to inhibit PMN leukocyte chemotaxis， and the peak of inhibition showed at
the concentration of 100 gegtml． Although， thele was a tendency to fail to suppress PMN leukocyte
chemotaxis in the concentration of 500 ptg／ml． The low levels of tetracy61ine may effe¢t the micro－
filaments of leukocytes， whereas the increased production of lactic acid by leukocytes in the presence
of 500 yg／ml of tetracycline may be a manifestation of metabolic effect of the drug， （c） Chloram－
phenicol in concentrations gf 25”g／ml， I QO ptg／ml and 500 ptg／ml inhibited’ the PMN leukocyte
chemotaxis， and the peak of inhibitiop was shown at．the concentration of 500 ptg／ml． ln the presence
of chloramphenicol， the increased productio’n of intracellular cyclic AMP in leukocytes restrict an
intact system of cytoplasmic microtubules．
［B］ Group of bladder tumors．
    1） Twenty patients with transitional cell carcinoma of the bladder were studied． lti all patients，
the mean value of PMN leukocyte chemotaxis was 3。1土0．3 cm． This value was almo忌t the same in
the・controls， and there was no statistical difference． However， the mean value of PMN leukocyte
che皿otaxis was 3．0±0．2 cm in the l 4 patients without infection， alld the皿ean value in the controIs
was 3・3±0・1 cm；this difference was statlstically significant（Pく0．05）． The results demonstrated
a depression in the chemotactic response of PMN leukocytes derived from patients with bladder tumdr．
The mechanism for depression of in vitro chemotactic responsiveness of’PMN leukocytes from tumor－
bearing individuals is not．known． It is postulated by experi皿ents in vitro that the chemotactic in－
hibitors ’ by tumor cells is effectual at Tetarding the migration of polymorphonuclear leu’kocytes．
    2） The mean value of PMN leukocyte chemotaxis in 7 patients under chemotherapy was almost
the same value in 13 patients under no－chemotherapy． However， many chemotherapeutic agents
produce neutropenia and impairement of the ability to stimulate hexose－monophosphate shtint activity
in PMN leukocytes which is an，established alteration of host defense which prediposes patiehts to
infections． lt is postulated that patients who are tr6ated with various chemotherapeutic agents either
singly or in combination may be at an increased risk of infecti6n due to functional impairement of
their PMN leukocytes even when their peripheral blood and bone marrow cells exhibit normal
morphology． ’ 一’
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Serratia marcescens 5株， Klebsiella Pneumoniae 4株，













































tmmunoglobu“n A， M， and G in 20 patients with pyelonephritis．
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M Trans． ca． G3
M Trans． ca． G2
M Trans． ca． G3
F Trans． ca． Gl
F Trans， ca． G2
M Trans． ca． G3
M Trans． ca． Gl
M Trans． ca． G2
M Trans． ca． G3
F Trans． ca． G3
6tl F Trans． ca． G2
80 M Trans， ca． G3
63 M Trans． ea． G3
36 F Trans． ca． G3
アア  M  ↑rans． ca． G3
63 M Trans， ca． G1
68 M Trans． ca． G2
69 M Trans， ca． G3
20 77 M Trans． ca． G2
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  ＊E．S．R． ： Erythrocyte sedimentation rate，
  ＊＊peri．W．B．C． ； Peripheral white blood cell’s count． （cells／mmS）
 ＊＊＊Trans． ca． G一 ： Transitional cell carclnoma Grade一．
＊＊＊＊U．T，1． ： Urinary tra¢t infection．
＊ ＊ ＊ ＊＊R．T．1． ： Respiratory tract infection．
赤血球の残りを取り出し，0．87％NH，Clで溶血させ
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Six series of three wells， 3 mm in diameter and spaced
3mm ’aPart are cut in each plate using the punch．
Atternative patterns for arrangement o’f tripticate wett series．
  A． bacterial chemotactlc factor
B・ PMN suspens‘rn〔（a）PMN・su5騰臣，1ぎεデーPC・（・）CER・（d）GM・
  C． control medium （Hanks）
                    Fig． 2






















Chemotactic activity of human polymorphonuc］ear leukocytes
with different concentrations of antimicrobial agent＄ and without
antimicrobial agent in cemparison with normal subjects and pyelonephritls．
Carbenici”in Cephaleridine Gentamicin Tetraeyeline ChloramphenicoLCentrel
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Linear distances of PMN leukocyte migration under microscopic measurement （x 40） ±




Random mob“ity of human pelymorphonuclear teukacytes wLth dlfferent
concentrations of antimicrobiai agents and without antimicrobial agent
in comparison with normal subjects and pyeionephritis．




































































Linear distances of PMN leukocyte migration under microscopic measurement （x 40） ± SEM （cro｝，
        Ca） ： normal sujects ： tb）： pyelonephritis．
Chemotactic actMty of human polymorphonuclear leukocytes
with clifferent concentrations of antimicrobia［ agents and without
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Random mobility of human polymorphonuclear leukocytes with different
concentratiofis of antimicrobial agents and without antimicrobial agent
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Distr；bution of chemotaxis and rendom mobility of leukocytes frorn the’??≠撃狽?
suject and the patient with pyeLonephritis or btadder tuvnor as expressed by mean
of agarose plate method．
                                   （cm）
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pyelo一 normal bladder pyelo一 normal
 －nephritis subjects tumor ． 一nephritis subjects
     （chernotaxis） ． （random mobility）
  （normal subjects；n富30． pyelonephriti5；n鴇20， bladder tumor；n＝20）








































Distrlbutlon of PMN leukocyte chemotaxis values about
the patient of bladder tumor，・ under chemotherapy and
no－chemotherapy． （anti－cancer agents）
   （cm）
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